focus -WSS

focus

author：leisure time 2025-09-28 00:49:06 - browse：898

Monica Bertagnolli -- Health Policy coverage from STAT — Monica Bertagnolli, the nominee to lead the National Institutes of Health Jeff Chiu/AP

Monica Bertagnolli, President Biden’s nominee to lead the National Institutes of Health, spent her confirmation hearing Wednesday stuck in the middle of Republicans’ and Democrats’ bickering over her agency’s role in high drug costs, ultimately refusing to commit to either party’s approach.

Bertagnolli similarly walked a line on government funding for gender-affirming care research and other hotly politicized health care issues, though she did stress that transgender youth are some of the country’s most vulnerable people.

The long-awaited hearing came months after Committee Chairman Bernie Sanders (I-Vt.) pledged to stall her confirmation process until Biden did more to address high drug prices, like an assurance that the NIH would insert reasonable pricing requirements into deals with commercial drugmakers.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： To bolster infectious disease surveillance, genomics powerhouses team up

hotspot

WSS

Why you shouldn’t ask, “What country has the best health care?”

Dog Aging Project founders on what lies ahead after losing funding

TikTok, Instagram influencers need more rules for drug ads

White House pharmacy plagued with problems, investigation finds

FDA sets aggressive timeline for overhauling inspection procedures

Dog Aging Project founders on what lies ahead after losing funding

focus

focus

Wikipedia

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Inaction leaves children at risk from dangerous chemotherapy drug

United colonoscopy coverage change 'may cost lives,' doctors say

A pediatrician calls for Congress to pass the child tax credit deal

Wildfire smoke exposes gaps in outdoor worker protections

A pediatrician calls for Congress to pass the child tax credit deal

Novavax promises a turnaround & Lilly roils the obesity market

Medicare drug price lawsuits could be good politics for Biden

Activists slam private health insurers over coverage restrictions

Zyn nicotine pouches become unlikely player in latest culture war

leisure time

Medicare drug price negotiation legal challenge met with skepticism

Merck CEO won’t testify in Senate, citing no expertise in drug prices

Bernie Sanders is gearing up to subpoena pharma CEOs

The inclusion problem at the heart of rehabilitation research

Maisha Meds is a PBM, but don't call it that

Merck CEO won’t testify in Senate, citing no expertise in drug prices

hotspot

hotspot

hotspot

entertainment